Back to RhumbLine Advisers RhumbLine Advisers

QNCXQNCX

Showing 1 of 17 quarters

Position history for RhumbLine AdvisersRhumbLine Advisers's holdings in QUINCE THERAPEUTICS INC

No. RhumbLine Advisers exited its QNCX (Quince Therapeutics) position in Q3 2024. Its Q2 2024 13F listed 394 shares worth $295. RhumbLine Advisers first reported QNCX in Q4 2019 and held it in 15 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$155.20
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used